Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On November 24th 2020 a gap was formed. If you go back to that day on the chart, look at the day before and see how ACB closed at $7.43. On the 24th ACB low pps for the day was?.... Believe it or not the exact same number that we closed at today, which was $8.51. Coincidence? So they tested $8.30ish only to let the pps come up to $8.60ish very briefly, and then for the most part we churned around $8.50 all day. Now they have used today’s information to formulate a plan to fill this gap from the 24th of November tomorrow! IMO, once this gap is filled, next week possible news will be released, also remember that Monday is the 12th which is exactly 2 weeks from Mexico’s deadline to officially legalize cannabis. What I am going to do tomorrow as I am in the red, like most that have invested in this sector, specifically Aurora Cannabis as of late, is average down! Once this hits mid $7’s tomorrow who knows how long it will stay at that pps, maybe just long enough for the non institutional investor to capitalize on it just for a very brief time. Depends on how many stop losses and panic sells we will have because of this “filling of the gap” tomorrow!
- GOOD LUCK EVERYONE -
-ACB
Interested to see how this one goes.. there is barely a resistance level at $3, and then there doesn’t look like much of anything to stop it to test resistance levels at $1.80 or so, then $1.30. Both those lower pps, it churned nicely for a bit before jumping up. Seems like a decent entry point at $3. But like I said this might go lower.. Definitely on the sidelines watching though! Good luck to everyone over here. If it gets pushed to a lower level it should have a significant bounce back to its current levels, and higher once all of this manipulation over the entire MJ sector is finished!
-OGI
Referencing Aurora in the near term and the article you provided a link to. I would simply say that businesses evolve. We are 4 months in to 2021, so that is approximately 40 months from 2018 when it officially became legal. Remember that is not counting the initial planning businesses envisioned before it even was legal way before 2018. So we are talking 4+ years of every MJ business for the most part, figuring out what worked and what didn’t work. Speaking of Aurora Cannabis specifically, they had a CEO they had to run out of there, along with a few others that was absolutely running the business in to the ground! Now that the new CEO has been there they have been signing deals all over the world. (There is Aurora Europe, and Aurora Nordic that nobody talks about) but we are talking about Aurora Canada and Mexico, so both of those I just mentioned really doesn’t pertain to what you are asking.
- first let’s talk about population. Canada’s 2020 population report says there are 37,742,154 people that reside there. Mexico’s 2020 population report says there are 128,932,753 people that reside there. So there are 91,190,599 more people that reside in Mexico.
- now let’s touch on geography. Canada is at the top of North America making import/export very difficult. (You even touched on how Aurora is having difficulty fulfilling supply to Australia a few weeks ago.) Mexico however is centrally located therefore making it easier to import/export to all countries, thru warmer waters and cannabis friendly southern borders. Remember that in the U.S. it is federally illegal so that has not been an option since it was legalized in 2018 up in Canada. So having a bunch of cannabis in Canada doesn’t really do you any good if it is almost impossible to export cannabis to other countries from Canada. Probably one reason why Aurora Canada downsized considerably in this last year. As far as supplying the European nation, that has not been a problem since Aurora Europe and Aurora Nordic exist. But, essentially exporting from Canada has obviously been a huge hurdle, and that is why those entities of Aurora Canada do exist.
- now let’s get to the (ace in the hole so to speak)
-TOURISM-
This is the link that I am basing all of these figures on below.
https://knoema.com/atlas/topics/Tourism/Leisure-Travel-and-Tourism-Spending/Leisure-travel-and-tourism-spending?type=maps
Canada versus Mexico
- Did you know that in 2017 before cannabis was legalized in Canada there was about 48.39 billion dollars made off of tourism. In 2018 Canada estimated 51.58 billion, and in 2019 one year after cannabis legalization there was an estimated 54.64 billion in tourism made.
In 2017 Mexico had an estimated 142.62 billion U.S. dollars from tourism, Mexico was also ranked as one of the top 10 countries with the largest tourism industry! In 2018 Mexico made an estimated 150.97 billion, which is still 1 billion more than Canada made that year. However in 2019 Mexico made 157.3 billion! Also remember, because this is very important. Mexico uses pesos! It takes 20.31 pesos to equal 1 American dollar, meaning a peso is the equivalent of 5 cents to the U.S. dollar. Where as 1 Canadian dollar is .80 to the U.S. dollar. With all that being said Mexico’s tourism industry more than triples Canada’s year over year!
- so one can only imagine how much money will be made in Mexico’s tourism industry once every adult that vacations to Mexico can legally possess an ounce of cannabis!
- Mexico is huge, they have beautiful beaches, it’s warm all year, and it is a place known to party and have a fun vacation! (Most people want these things included in their vacations!)
- no offense to Canada, but if a person, family, group of friends, etc, etc.. Wanting to go to a nice tropical place to be warm, and enjoy the ocean without a wetsuit then you are probably not going to take a trip to Canada...
That is just not my opinion, but a fact shown by revenue of the tourism industry.
- now add that not only can you have a warm wonderful time in Cabo or one of the many other beautiful beaches in Mexico on your vacation, a tourist will now also be able to buy, and posses up to an ounce of cannabis as well. I think we shall see the old peso getting awfully closer to the U.S. dollar in valuation very, very quickly!
- also, and this is my opinion. Just like there are Aurora Europe, and Nordic there will soon be an Aurora Mexico as Aurora Canada already owns a significant piece of Mexico’s medicinal cannabis market when they partnered with Farmacias Magistrales S.A. whom has over 80,000 retail points for the sale of CBD products, as well as over 500 pharmacies and hospitals for the distribution of THC products.
-ACB
Yeah. I think there will be an Aurora Mexico, and I agree that they are most likely trying to get involved with someone in the U.S. I don’t think however that Aurora will be bought out as they are already IMO the most dominant in the MJ sector. IMO, what they need is to partner up with a company in the U.S. that is as big or bigger than they are to get more of a position in the U.S. and I also presume that eventually if the U.S. in fact federally legalized cannabis in the U.S. Aurora would then build a headquarters in the U.S. as well..
-ACB
I don’t think Aurora Cannabis filing with the SEC at the same time Mexico chamber of deputies approved cannabis legalization is a coincidence. I am expecting merger/acquisition announcement from Aurora any day now. As far as recreational vs medical in Mexico. I would presume that medical will be more, especially at first. As there are so many medicinal uses for cannabis, it will be used in conjunction with hospitals, doctors, etc. Also adults over the age of 30ish probably will first feel more comfortable going thru medical at first. So I believe that’s where the real money will initially be made. But as it stands with any adult able to posses an ounce of flower, a lot of people (probably eventually most of the adult population in Mexico) will posses cannabis in some shape or form. So I would assume recreational should be real big as well. Bottom line Mexico legalization is huge as other countries will feel more confident about legalization as well. Especially when they see how much money Mexico will have coming in. Also, people are not talking about import/export, and all the other avenues this will open up under a full scale legalization of Mexico.
As far as the short interest on ACB. The reason it’s lower currently IMO, is the fact that most shorted positions were covered by April 1st which I believe there was some kind of deadline I read somewhere about April 1st being some kind of cut off while the SEC investigates everything. I mean do you really think it’s a coincidence that all MJ sector has been shoved down our throats and predominantly every investor in this sector is in the red now? It was all of the institutional investors covering all of their short positions before Mexico finalizes legalization, the safe banking act is passed and ultimately the U.S. and other countries legalizing cannabis as well. Shorties got hurt real bad with that company a couple months ago that started this whole investigation in to short selling, and they don’t want to lose even more money on shorting MJ plays with all of them about to boom!
I only get 3 posts a day, so I had to fit both topics in to this one reply as this is my third for the day!
-ACB
So sad how desperate some people are! Judging by the lack of volume the last week or so, it seems like for the most part everyone is holding, and for good reason!
https://technical420.com/cannabis-article/mexicos-top-lawmakers-have-said-that-the-proposed-adult-use-cannabis-bill-will-be-passed-in-its-current-form/#
- Companies like Canopy Growth Corporation (WEED.TO) (CGC), Aurora Cannabis Inc. (ACB.TO) (ACB) and Khiron Life Sciences Inc. (KHRN.V) (KHRNF), are highly focused on the Mexican cannabis market and we are closely following this market.
https://www.marijuanamoment.net/bipartisan-state-attorneys-general-urge-congress-to-pass-marijuana-banking-bill/
https://www.google.com/amp/s/www.ganjapreneur.com/federal-cannabis-legalization-bill-coming-soon-says-schumer/amp/
- Sen. Schumer’s announcement came on the same day that Gov. Andrew Cuomo signed into law the formal legalization of adult-use cannabis in New York, the Majority Leader’s home state.
In January, Schumer hinted that lawmakers planned to merge several pieces of cannabis legislation in their quest for federal reform.
-ACB
This is the problem, and to all Aurora Cannabis investors don’t let these people cover their short positions by scaring you out of the shares you own!
https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nyse-acb-options-data-report-2021-04/amp/
First paragraph from the link:
- Aurora Cannabis Inc. (NYSE:ACB) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 26,690,000 shares, a growth of 31.9% from the February 28th total of 20,230,000 shares. Approximately 13.6% of the company's shares are short sold. Based on an average trading volume of 23,200,000 shares, the short-interest ratio is currently 1.2 days.
- if you have been watching this stocks volume we haven’t gotten over around an average of 10 million at most for a couple of weeks now.. I am not looking at any charts to see the exact volume of each day, but if I remember correctly almost all week we have barely traded 6 or 7 million shares. Remember that the volume of daily shares are counted both ways, meaning really half of that has traded hands. So IMO 26+ million shares short is about 2 and a half weeks of trading around 6-7 million daily volume...
- So don’t fall for the illusions that people with a lot of money and interest in Aurora are creating and sell your shares, as they will gladly buy them up along with anyone else averaging down or just starting to take a position in Aurora and can’t pass up such a good deal! If you don’t sell your shares then once news makes this pop, it will skyrocket even more than it would normally. As this will then make shorts lose their positions, and cover before they go broke! Kind of like what happened with GameStop about 2 months ago, and believe me the SEC has already opened an investigation which will soon make this unethical way of screwing investors a thing of the past. As it’s about to get a lot more regulated!
https://www.google.com/amp/s/www.cnbc.com/amp/2021/02/01/sec-could-set-short-interest-caps-hike-trading-taxes-to-combat-wild-moves-analysts-say.html
-ACB
Seems like this is a very big agenda for Schumer, especially since New York just went legal. That is his state he represents, IMO the Safe banking act will be pushed thru very quickly (end of the month quick!) But as far as full scale cannabis legalization on the federal level probably will happen over the summer..
The real catalyst will be between now and the end of April when Mexico’s deadline is to sign cannabis in to law! So, IMO there is a gap at $7.50 that has been waiting to be filled since Biden was elected. More than likely “the man” is going to try there hardest to get it to that point if there is still not a lot of buying being done yet. But come the end of April, possibly as soon as next week the whole MJ sector will pop! Also remember SEC just approved their billion shares which is basically running parallel with Mexico. IMO, very shortly Aurora will be announcing an acquisition, or merger news as well. So get your cheapies while you can, and if we do fill the gap at $7.50 you better believe I am averaging down a bit, and loading the boat!
-ACB
Medical cannabis ‘made in Denmark’
17th March 2021
Medical cannabis ‘made in Denmark’
© Aurora Europe GmbH
How Aurora Europe is ensuring reliable access to high-quality medical cannabis for Europe and beyond.
There is growing recognition in Europe and across the world that medical cannabis can help patients in need. Across Europe, the number of countries allowing access to medical cannabis is increasing. Some of these countries still limit prescriptions to only the severest of cases, while others offer a broader approach – for example, Germany, an established market, recently reached the 100,000-patient mark and physicians have been able to prescribe the medicine for a comparatively wide range of conditions since April 2017. But when that patient data is compared with established medical markets like Canada, where 1% of the population have a medical cannabis prescription, the gap in access is substantial.
Aurora Europe, headquartered in Berlin, Germany and with subsidiaries across the continent, is dedicated to improving patients’ lives, supplying high-quality products and educating doctors. Aurora, a global leader in the cannabis industry, has a proven track record of supporting the advancement of international medical cannabis markets alongside government bodies and with a deep commitment to regulatory compliance. The company is already well established as the leader in the dried flower market segment in Germany, and its approach has won it similar leadership positions in Poland and the UK. From its facility in Denmark, the company is seeking to expand its footprint; and alongside other market leaders, it is set to supply product to the recently established French pilot programme.
Product availability and time to market are key
Aurora Nordic, the most recent addition to Aurora’s network of EU Good Manufacturing Practice (GMP) facilities, delivers high-quality, premium medical cannabis to patients in Europe – and soon, internationally. With more than 9,200m2 of greenhouse production space (1.5 football fields) and a maximum output of approximately 10,000kg per year, Aurora Nordic will become Aurora’s main supply source for the European market. This high-tech cultivation facility in Odense, Denmark produces dried flowers and extracts and will introduce other formulations in the near term.
“The benefits of a European-based facility are obvious: shorter time to market, reliable delivery while maintaining the same quality and effectiveness of the products,” said Dr Axel Gille, President of Aurora Europe.
Innovation and flexibility: the differentiators for success
When Aurora decided to invest in an operational facility in Europe, it was clear that its design should facilitate efficient processes, in order to bring products to market quickly and be as flexible as possible. Being a relatively young industry, flexibility is important in every aspect of production and supply chain management within the cannabis sector. Fast adjustment to today’s market needs, in terms of production capacity and cultivars and the ability to produce innovative formulations for the future, had to be made possible under one roof.
When planning the refit of the greenhouse, processes were designed and equipment embedded based on scientific evidence and strict risk parameters.
“While implementing what we already knew, we worked against a holistic quality risk assessment across the entire production process and challenged each and every step,” explained Lasse Rasmussen, General Manager of Aurora Nordic. “This innovative approach may be perceived as leaner and easier to maintain during the commercial operation, but it does not diminish the quality standards and enables us to focus on the ‘critical-to-patient’ aspects of the products.”
In less than a year, the refit of the greenhouse was ready to welcome mother plants from Canada and to start the validation processes. In late 2020, the first commercial product left Aurora’s Danish facility. “But this milestone was not the end,” Rasmussen added. “With each harvest we accumulate new data and new knowledge to continuously refine and improve the way we do things. While we are creating more efficient processes, the quality is not compromised. Through our eagerness to explore and innovate, we will deliver products for patients in need to make a difference in their lives.”
Medical cannabis ‘made in Denmark’
Above: Jean Monin, Chief Commercial Operations Officer of Ethypharm. Below: Dr Axel Gille, President of Aurora Europe © Ethypharm © Aurora Europe GmbH
Medical cannabis ‘made in Denmark’
France: Enabling medical cannabis access for patients
Aurora Europe and the Ethypharm Group were selected as the primary supplier of all three dried flower lots for the French medical cannabis pilot programme. These lots encompass high-THC, balanced and high-CBD products. The entire supply of dried flower medical cannabis to French patients during the pilot programme will therefore be provided by the Aurora-Ethypharm collaboration.
“This is an important milestone and a great success for Aurora in our effort to improve the status and accessibility of medical cannabis in Europe,” Gille commented. “Supplying high-quality medical cannabis dried flower to the French pilot programme is the first and very important step towards providing better access and will support the destigmatisation of medical cannabis in France.”
Aurora and Ethypharm signed a collaboration agreement in October 2020 to serve the government-initiated programme, leveraging both parties’ expertise. Under the terms of this exclusive partnership for the French territory, Aurora will supply medical cannabis sourced from Aurora Nordic, as well as manufacturing and logistics support. Laboratoires Ethypharm will be responsible for distribution and pharmacovigilance activities in France.
“We are very proud to be part of the solution for patients seeking medical cannabis treatment. There is a clear unmet need for patients, in particular for the ones with severe pain refractory to current treatments. Within this very structured programme, we bring our deep expertise both in central nervous system disorders and in distribution of highly regulated medicines,” explained Jean Monin, Chief Commercial Operations Officer of Ethypharm and co-ordinator of this partnership. “Collaboration and partnerships are part of Ethypharm’s DNA. We always work with the optimal partner, in any country or region of the world. Combining our skills with Aurora’s pharmaceutical-quality cannabis products is, in our view, the right approach to build long-term trust and confidence in medical cannabis in France.”
The French pilot programme is one of the most formal medical cannabis pilot programmes to date. The framework clearly outlines the supply of three different medical cannabis product types (flowers, extracts and capsules) to 3,000 patients across five indications (neuropathic pain, spasticity, palliative situations, cancer and epilepsy) over a timeframe of up to 24 months. Aurora’s products are expected to be used in treating patients with all indications except epilepsy.
There are three key differentiators of the French pilot programme compared to other markets:
The provision of finished products instead of APIs in other more mature markets such as Germany
Free access to product for the patients in the pilot
A mandatory education programme to enable healthcare practitioners to integrate medical cannabis into their therapeutic toolbox. A nationally harmonised curriculum has been established by the health authorities to ensure consistent education across prescribers (doctors) and dispensers (pharmacists)
“If successful, this pilot programme could lead to a regulated market for medical cannabis in France, which would be one of the largest in Europe,” said Gille.
Poland: first successes in an Eastern European market
Three years after the introduction of legislation allowing the use of medical cannabis in Poland, the market is still at an initial development stage.
The framework is relatively liberal – any doctor can prescribe an initial three months’ therapy – but so far, there is no reimbursement available for patients. Despite numerous announcements, Aurora and Canopy Growth are the only two companies with registered products. A total of six products have received marketing approval as of February 2021: ‘Cannabis flos AURORA DEUTSCHLAND GmbH’ in the four varieties THC:CBD 20:1, 22:1, 8:8 and 1:12; and two dried flower products by Canopy Growth.
The changes in the Polish market between 2019 and 2020 were noticeable, both in the space of public discussion and in patient numbers and prescriptions. From October 2019 to January 2021, the number of prescribing physicians in Poland increased from 15 to 50 and patient numbers went from 300 to around 1,500. Import volumes are on the rise too. In both December 2020 and March 2021, Aurora imported 60kg of flowers, compared to 81kg for the entire Polish market in the whole of 2020. The early and expanding market resulted in pressure on supply chains and stock shortages in 2020. However, as a result of good co-operation between regulatory authorities and the industry, supplies have improved to meet the growing interest and demand from physicians and patients.
Comparing Poland with established medical cannabis markets, it is estimated that approximately 300,000 patients could benefit from medical cannabis. Certainly any form of reimbursement, even a partial one, would influence the speed of market development. In summary, it is important to ensure product availability and access, register extracts and continue all efforts to educate physicians and transfer knowledge from established markets like Germany to Polish doctors.
Medical cannabis ‘made in Denmark’
© Aurora Europe GmbH
The UK: A rapidly developing market with huge potential
It is a little over two years since the UK rescheduled cannabis-based products for medicinal use; and, while several barriers to wider access remain, much has changed since then. During 2020, the UK market saw rapid growth in prescriptions of unlicensed cannabis medicines, with patient numbers now estimated to be in the region of 2,500. While this is still low when measured against what is a significant market potential, it represents a healthy increase over 2019 and there are signs of momentum that bode well for the future.
“We have seen some positive developments in the industry,” said Don Perrott, Aurora’s Managing Director for the UK and Ireland. “We and our partners are seeing encouraging increases in patient numbers and we expect this to continue as the prescribing physician base grows, product ranges increase, and medicines become more affordable.”
The investment climate in the UK has also shifted gear, following guidance from the Financial Conduct Authority in September 2020 on the listing of medical cannabis businesses on the London Stock Exchange. “This is welcome news for the industry,” said Perrott.
“Not only does it help to remove confusion and provide a legitimate avenue for UK companies to raise much needed capital, but it helps to create awareness and to reduce some of the stigma associated with medical cannabis which is an important step in the right direction.”
However, despite these positive developments, there are still real impediments to meaningful access and reimbursement. “We have a two-tier system in the UK and one that is failing patients who do not have the financial means to pay for medicines privately,” said Perrott.
“Many patients who could benefit from medical cannabis are being forced into the illicit market, which is unacceptable.” While an ever-increasing body of evidence exists in support of the efficacy of cannabis as a medicine, the National Institute for Health and Care Excellence (NICE) has made it clear that there needs to be more clinical evidence before further positive recommendations can be made. “Generating clinical data is an absolute priority, but it is also imperative that the industry works together with the healthcare authorities to find ways to improve access for patients in need whilst this evidence generation is ongoing,” said Perrott.
Why would they dilute this already really low pps? If they put all those shares in to market they would be delisted in a month for not being over a $1 pps... IMO News about acquisition, or merger will be out very soon as now that this has been approved. They can move forward with whatever company, or companies they choose to acquire. Remember, this is all being done during a deadline of April 30th for Mexico to get cannabis fully legalized and running over there. Aurora has been very quiet as of late. I expect very big news between now and the end of April. Until then if it finally fills the gap at $7.50, so be it. I will just add to my holdings!
Patience is key right now with this company, IMO.
-ACB
Did we all forget about Aurora Europe?
https://www.healtheuropa.eu/medical-cannabis-made-in-denmark/106686/
https://www.pedanios.com/aurora-medicine/media/aktuelles/pressemitteilungen/210126_aeu_ethypharm_en_f.pdf
https://www.globenewswire.com/news-release/2021/03/17/2194641/0/en/Clever-Leaves-and-Ethypharm-Announce-German-Pharmaceutical-Cannabis-Partnership.html
Aurora Cannabis IMO, will soon show without a doubt that they are in fact the absolute dominant global MJ company in the world, very, very soon!
-ACB
Nice find! Here is the link for the Aurora deal with Cantek.
https://www.tipranks.com/news/aurora-cannabis-inks-supply-deal-with-israels-cantek/
-ACB
Mexico’s cannabis legalization has almost made it to fruition.
https://www.google.com/amp/s/www.nytimes.com/2021/03/10/world/americas/mexico-cannabis-bill.amp.html
America is next!
https://www.marijuanamoment.net/chuck-schumer-says-federal-marijuana-legalization-is-a-priority-in-democrats-big-bold-agenda/
Aurora Cannabis has been in Mexico since 2018!
https://marketrealist.com/2019/11/aurora-cannabis-runs-mexicos-cannabis-market/
Aurora owns the most dominant CBD brand in the US!
https://www.prnewswire.com/news-releases/aurora-cannabis-completes-acquisition-of-reliva-llc-301067122.html
Aurora main MJ company supplying Israel!
https://www.prnewswire.com/news-releases/aurora-cannabis-announces-israeli-medical-supply-agreement-with-cantek-301180472.html
Aurora in France?
https://www.google.com/amp/s/www.fool.com/amp/investing/2021/01/27/aurora-cannabis-and-tilray-to-supply-experimental/
Bottom line, Aurora Cannabis is everywhere, inking deals globally with dominant companies all around the world!
-ACB
Read this. It was just released 2 hours or so ago. First let me say people posting these false pictures of Aurora Cannabis, using old information (before the new CEO took over) and twisting news of Aurora selling property as they are shutting their doors, and the new CEO is just bleeding them dry to close Aurora’s doors should be ashamed of themselves! This is people’s livelihoods, and savings they are whole heartedly using to invest only to be scared to sell at a 25-50% loss, so shorts can cover or institutions can own more shares. People. Know what you hold! This is the biggest, dominating, global MJ company out there, and IMO, are about to buy out a company, if not a few, and/or merge with one, or a few and that’s why they filed with the SEC for the billion shares! Mexico is literally a month away at most from allowing full scale legalization of cannabis and Aurora owns most of that market already! Anyways here is a link full of facts from the 24th of March 2021. Enjoy!
https://www.google.com/amp/s/www.marketbeat.com/instant-alerts/nyse-acb-consensus-analyst-rating-2021-03-2-3/amp/
-ACB
https://www.foxbusiness.com/technology/u-s-sec-sues-california-trader-for-alleged-social-media-fraud-scheme
Conspiracy theory my @ss! This guy got caught doing it. Tell me Aurora is not being heavily manipulated! Shorts have almost 35% of the volume this last couple weeks!
-ACB
Average down.. if you are trading stock, you should know to have a back up plan. You should of been averaging down these last two weeks! What is with all this hate on Aurora? No one is bringing up how they are the globally dominant MJ play out there. Signing huge deals with companies in Germany, France, Australia, Israel, Europe, Mexico, and the U.S.
https://www.newcannabisventures.com/aurora-cannabis-resumes-german-sales-and-adds-third-eu-gmp-certification/
https://www.google.com/amp/s/mjbizdaily.com/aurora-cannabis-inks-deal-to-supply-australia-market/
https://www.prnewswire.com/news-releases/aurora-cannabis-announces-israeli-medical-supply-agreement-with-cantek-301180472.html
https://www.google.com/amp/s/mjbizdaily.com/aurora-says-its-danish-cannabis-has-reached-german-pharmacies/
https://www.pedanios.com/aurora-medicine/media/aktuelles/pressemitteilungen/210126_aeu_ethypharm_en_f.pdf
https://marketrealist.com/2019/11/aurora-cannabis-runs-mexicos-cannabis-market/
https://www.prnewswire.com/news-releases/aurora-cannabis-to-strategically-enter-the-united-states-with-acquisition-of-reliva-llc-a-market-leading-mass-retail-cbd-platform-301063067.html
Let’s talk about some of this news that’s happened primarily in the last 2-3 months!
-ACB
He needs to provide proof. If they have indeed went thru the 500 million, then that means they have probably used it to ink a merger deal soon to be announced, as the SEC has 90 - 150 days to approve the 1 billion. So it would make sense for them to put in to them for review since it takes 3-6 months for approval..
Aurora has been real quiet as of late, and still a lot of hate being thrown their way! Something tells me some BIG news is about to be dropped! Also Aurora CEO has been making a few appearances on different news outlets very recently. Thinking this might run starting tomorrow!
-ACB
-ACB
Provide link to your claims please. As the video I just posted the other day clearly shows they have plenty of liquid cash, and are setting up for an acquisition or merger of some kind...
-ACB
CEO talking about Aurora, and reiterated how they still have over a half a billion, meaning it hasn’t been blown thru like others on this board are insinuating!
https://www.google.com/amp/s/finance.yahoo.com/amphtml/finance/video/mexico-moves-closer-legalizing-marijuana-024502447.html
-ACB
Yeah. I don’t think it was a coincidence. Maybe we will wake up to some news of a merger in the works. That would be fantastic!
-ACB
https://media2.mofo.com/documents/faqshelfofferings.pdf
Read up
They are only doing this right now because they know something is about to make this thing run!
-ACB
They are buying out a company, or merging with one. Bet!
- ACB
First of all I am pretty sure it doesn’t go in to effect right away. The SEC has 90-150 days I believe to approve this. This is also funny how this gets dropped right before Mexico legalization, and the announcement of the new stimulus which a ton af analysts predict most to invest a good % of their stimulus in the market. This smells more like they are about to buy out or merge with a company and they are going to pay them in shares of Aurora.
-ACB
Watch the video up top of the article!
https://www.bnnbloomberg.ca/marijuana/video/aurora-targets-mexico-in-new-pot-deal~1560776
-ACB
Obviously you did not read the article... Tgis is the important part...
- How ACB is targeting the Mexican cannabis market?
Aurora Cannabis (ACB) is the only prominent Canadian cannabis player with a real stake in the Mexican market. On December 7, the company announced a supply partnership with Farmacias Magistrales S.A. The latter is a major pharmaceutical manufacturer and distributor in Mexico. Then, the legal medical marijuana market in Mexico was targeting 130 million people.
On December 10, Aurora Cannabis announced that it planned to buy Farmacias Magistrales SA. Farmacias was the first company to secure import licenses for raw materials containing more than 1% THC (Tetrahydrocannabinol) in Mexico. According to Aurora Cannabis’ press release, Farmacias will use the imported raw materials to make medical cannabis oil products.
-ACB
Your to funny! Read the link you seem to not talk about...
https://marketrealist.com/2019/11/aurora-cannabis-runs-mexicos-cannabis-market/
-ACB
I would say if it keeps going down they are going to test that $12-$13 level resistance. Earnings come out on the 9th I believe, and you usually have to be careful during that period of time. I haven’t been in this stock for awhile but I would assume someone is going to make whatever comes out negative to try and push it down further. But it could also pop as well if it gets pushed down enough for shorts to cover enough before a huge run because financials come out better than expected....
-CURLF
lol. We are talking about the one in Arizona. But, it’s actually 100, here is the link so you can educate yourself
https://ir.curaleaf.com/2021-02-10-Curaleaf-Celebrates-the-Grand-Opening-of-Its-100th-National-Retail-Location
-CURLF
No worries then. I must of misunderstood, thanks for the reply! Out of all the MJ plays right now, I think this company is one of the best. Especially if you are looking at the U.S. market. As far as globally you will have to look at the other board I post on to see where I think that MJ play is??. Anyways, love me some Curaleaf! Good luck to you and everyone else. Hold strong thru all of this shorting going on! It’s happening with all of the MJ plays right now.
-CURLF
Your too funny! If you had any idea how the first states that have been doing it since dispensaries were aloud in the U.S. are doing it you wouldn’t reply to me like I am an idiot. Everything is online and curbside pickup. Just like your food! So if your in a state that gives a sh*t still about the virus that has killed over 500,000 Americans you would think them doing it in a bank with a sort of drive thru system would be a great idea.. Do you go to Walgreens because of their drive thru? I know that’s why most people choose to go there specifically is the drive thru convenience! So yes any sort of building they don’t have to accrue the cost of actually building, that is designed to not only help walk in customers but also medical patients that might be sick with weak immune systems the option of a drive thru system. Well I say that’s fantastic, as with out all of the plants Medicinal use you would of never been able to walk in to a store and buy it practically everywhere in the U.S. now..
-CURLF
https://www.google.com/amp/s/mjbizdaily.com/canadian-pension-fund-unloads-some-cannabis-shares-adds-aphria/amp/
- PSP also added to its Aurora Cannabis holdings.
PSP added about 1 million Aurora shares between the end of 2018 and May 2020, when Aurora’s reverse stock split came into effect.
Since then, the pension manager nearly doubled its Aurora position to 514,612 shares.
-ACB
Stay up to date on the latest and greatest no one talks about from Aurora!
https://www.google.com/amp/s/mjbizdaily.com/aurora-says-its-danish-cannabis-has-reached-german-pharmacies/amp/
- “We started to deliver to the first pharmacies who ordered the product from us,” Yvonne Moeller, the company’s director of communications for Europe, told Marijuana Business Daily via email.
She said more than 150 pharmacies have the products, which were made at Aurora Nordic in Denmark.
“Last week, the (first) medical cannabis products ‘Made in Denmark’ reached German pharmacies,” Aurora Deutschland GmbH announced on LinkedIn.
The move is part of Aurora’s plan to meet demand in the EU using its European-based production.
-ACB
Let’s talk how this investment firm just increased their stake in Aurora cannabis exponentially as well.
https://www.google.com/amp/s/www.barrons.com/amp/articles/fund-bought-up-marijuana-stock-aurora-cannabis-mastercard-sold-visa-shopify-51613142795
- BCI, as the pension is known, declined to comment on the investment changes. It manages $135 billion in assets.
BCI bought 232,058 additional shares of Aurora Cannabis to end 2020 with 290,404 shares.
- Firm handles 135 billion in assets increases their shares from roughly 58,000 to almost 300,000 shares, but nobody is talking about this either....
-ACB
https://fintel.io/so/us/acb/etf-managers-group
- Etf Managers Group, Llc ownership in ACB / Aurora Cannabis Inc.
2021-01-28 - Etf Managers Group, Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7,809,859 shares of Aurora Cannabis Inc. (US:ACB). This represents 4.24 percent ownership of the company. In their previous filing dated 2021-01-08, Etf Managers Group, Llc had reported owning 7,482,322 shares, indicating an increase of 4.38 percent.
Other investors with positions similar to Etf Managers Group, Llc include Vanguard Group Inc, and Citadel Advisors Llc.
- Is this what you are referring to?
- ACB
Gap up right below $14, and a huge one between $17-$18. See if we fill them this week. With the amount of money on hand Aurora has makes me wonder if they are about to make an offer to buy out someone very soon!
https://www.google.com/amp/s/www.barrons.com/amp/articles/pr-aurora-cannabis-announces-fiscal-2021-second-quarter-results-01613087218
- Combined with $565 million in cash on our balance sheet today, Aurora will continue to be a long-term player in the global cannabinoid market and increasingly positioned to deliver for shareholders over the long run."
-ACB
Article basically states Aurora owns a stake in this new company booth is CEO of. At the bottom of the article he says he would not be opposed to the company he is now CEO of to work together with Aurora in the future. This is great, this is more money coming in for Aurora until 2028 and IMO, Booth will never work for Aurora directly again. He is the one that diluted the heck out of all the shareholders and that’s why Aurora appointed a new CEO with a real business strategy that seems to be working rather nice!
- Despite the distance between Aurora and Australis, the two companies are still linked by way of a set of warrants held by Aurora, which won’t expire until September 2028.
In its most recent quarterly report, Aurora restated its current position in regards to Australis. Company documents show Aurora still holds 22.6 million warrants exercisable at a price of $0.20 per share; in total, these warrants equate to around a 20 percent stake in Australis.
The Canadian producer also reaffirmed it cannot act on these warrants until US federal law permits all of Australis’ business operations, or until Aurora receives permission to act on them from securities regulators. The latter would likely not happen without federal legalization.
But where exactly does that leave the current business relationship, if any at all, between the two corporations? Booth told INN he wants there to be one and said he is looking forward to potential discussions with Aurora.
“Some people may see that warrant thing as a hangover, but I intend to nurture the relationship with Aurora,” Booth said.
The executive reiterated that for any action to take place with the warrants, cannabis will have to be deemed legal in the US. But in the future, if there is a change in policy in the US market and the warrants came into play, he wouldn’t turn down the opportunity to work with Aurora.
“A lot of factors would say that they wouldn’t do it. And a lot of reasons that I wouldn’t be bothered if they did,” Booth said. “If you know me, you know I’ll look at any deal. You know I don’t harbor resentment (toward) anybody. Sure, there’s some people that pissed me off at Aurora, they still do, but most of them have left after I left. I don’t expect that would impede me or them from doing business together.”
-ACB